Creating a clinical model for primary Sjögren's syndrome using both traditional Chinese and Western medicine
Official title: Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese Medicine and Western Medicine Based on Multi-omics
Run by China-Japan Friendship Hospital · NCT06528197 · Data updated 2026-11-12
This study is trying to combine traditional Chinese medicine with Western medicine to see if it can improve how we diagnose and manage primary Sjögren's syndrome in patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | July 4, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | July 30, 2024 |
| Trial ID | NCT06528197 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who meet the classification criteria for primary Sjögren's syndrome.
✕Probably not a fit
Patients with comorbid connective tissue diseases or severe health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a large cohort of patients diagnosed with primary Sjögren's syndrome. It will collect multi-omics data to develop models for disease diagnosis and prognosis prediction. By integrating traditional Chinese medicine with Western medical approaches, the study seeks to enhance understanding and management of this condition. The research will involve collaboration among several prominent hospitals in Beijing.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and prognostic tools for patients with primary Sjögren's syndrome.
How similar studies have gone: While the integration of traditional Chinese and Western medicine is a novel approach, similar studies have shown promise in enhancing patient outcomes in other conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome. Exclusion Criteria: * Comorbid connective tissue disease other than the disease under research. * Women who are pregnant or breastfeeding. * Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors. * Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.
Where it's running
-
Jiaqi Chen
Beijing, Beijing Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using PSMA and FAPI PET scans to map salivary gland function and inflammation in Sjögren's syndrome
This study will test whether combining PSMA and FAPI PET scans can better show salivary gland function and inflammation in people with primary Sjögren's syndrome.
-
Anti-CD19/BCMA U CAR-T cell therapy for relapsed or refractory autoimmune diseases
This pilot will test whether anti-CD19/BCMA U CAR-T cells can help adults with relapsed or refractory autoimmune diseases such as SLE, systemic sclerosis, Sjögren's syndrome, and rheumatoid arthritis.
-
Impact of Sjögren's syndrome on quality of life and costs
This study is trying to see how small fiber neuropathy affects the quality of life and costs for people with Sjögren's syndrome.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.